Maturation of blood vessels by haematopoietic stem cells and progenitor cells: Involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation

Thrombosis and Haemostasis

Volumn 101, Issue 6, 2009, Pages 999-1005

  Takakura, Nobuyuki ^a   Kidoya, Hiroyasu ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Angiopoietin 1; Apelin; APJ; Haematopoietic progenitor cells; Haematopoietic stem cell; Tie2

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; APELIN; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA; POLYPEPTIDE; PROTEIN KINASE C; RAF PROTEIN; APLN PROTEIN, HUMAN; APLNR PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; BLOOD VESSEL DIAMETER; CARDIOVASCULAR SYSTEM; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SPHEROID CELL; UMBILICAL VEIN; VASCULAR RING; XENOPUS; ANIMAL; BLOOD VESSEL; BOVINAE; CYTOLOGY; EMBRYOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOPOIETIN-1; ANIMALS; BLOOD VESSELS; CATTLE; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MORPHOGENESIS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, TIE-2; RECEPTORS, G-PROTEIN-COUPLED; XENOPUS;

EID: 67049156727     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-06-0358     Document Type: Conference Paper

References (57)

1. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674. (Pubitemid 27193480)
2. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999; 13: 1055-1066. (Pubitemid 29233137)
3. Oettgen P. Transcriptional regulation of vascular development. Circ Res 2001; 89: 380-383. (Pubitemid 34132653)
4. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660. (Pubitemid 36749213)
5. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003; 314: 15-23. (Pubitemid 37409909)
6. Simon MC. Vascular morphogenesis and the formation of vascular networks. Dev Cell 2004; 6: 479-482. (Pubitemid 38456177)
7. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998; 93: 741-753. (Pubitemid 28257581)
8. Adams RH, Wilkinson GA, Weiss C, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999; 13: 295-306. (Pubitemid 29095801)
9. Zhong TP, Childs S, Leu JP, et al. Gridlock signalling pathway fashions the first embryonic artery. Nature 2001; 414: 216-220. (Pubitemid 33051237)
10. Morawietz H, Breier G. Endothelial cell biology: an update. 5th International Symposium on the Biology of Endothelial Cells. Thromb Haemost 2006; 95: 1025-1030.
11. Lindahl P, Johansson BR, Leveen P, et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277: 242-245. (Pubitemid 27446080)
12. Dumont DJ, Gradwohl G, Fong GH, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8: 1897-1909. (Pubitemid 24273890)
13. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70-74.
14. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin- 1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-1180. (Pubitemid 27010101)
15. Feng Y, vom Hagen F, Pfister F, et al. Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb Haemost 2007; 97: 99-108.
16. Lubarsky B, Krasnow MA. Tube morphogenesis: making and shaping biological tubes. Cell 2003; 112: 19-28. (Pubitemid 36106415)
17. Kamei M, Saunders WB, Bayless KJ, et al. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 2006; 442: 453-456. (Pubitemid 44264794)
18. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980; 288: 551-556. (Pubitemid 11223680)
19. Parker LH, Schmidt M, Jin SW, et al. The endothelial- cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 2004; 428: 754-758. (Pubitemid 38514720)
20. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998; 282: 468-471. (Pubitemid 28483672)
21. Cho CH, Kim KE, Byun J, et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 2005; 97: 86-94. (Pubitemid 40982326)
22. Thurston G, Wang Q, Baffert F, et al. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 2005; 132: 3317-3326. (Pubitemid 41167158)
23. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676. (Pubitemid 36749215)
24. Kidoya H, Ueno M, Yamada Y, et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 2008; 27: 522-534. (Pubitemid 351225682)
25. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-476. (Pubitemid 28505047)
26. Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538: 162-171. (Pubitemid 32402239)
27. Masri B, Knibiehler B, Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 2005; 17: 415-426. (Pubitemid 39643060)
28. O'Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136: 355-360. (Pubitemid 24049270)
29. Devic E, Rizzoti K, Bodin S, et al. Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 1999; 84: 199-203. (Pubitemid 29331675)
30. Edinger AL, Hoffman TL, Sharron M, et al. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 1998; 72: 7934-7940. (Pubitemid 28421785)
31. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, et al. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 2003; 41: 354-370. (Pubitemid 36314149)
32. De Mota N, Reaux-Le Goazigo A, El Messari S, et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 2004; 101: 10464-10469. (Pubitemid 38924948)
33. Devic E, Paquereau L, Vernier P, et al. Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis. Mech Dev 1996; 59: 129-140. (Pubitemid 26379334)
34. Katugampola SD, Maguire JJ, Matthewson SR, et al. [(125)I]-(Pyr(1)) Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 2001; 132: 1255-1260. (Pubitemid 32234709)
35. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004; 118: 119-125. (Pubitemid 38296725)
36. Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002; 91: 434-440. (Pubitemid 35034212)
37. Ashley EA, Powers J, Chen M, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005; 65: 73-82. (Pubitemid 40038480)
38. Ishida J, Hashimoto T, Hashimoto Y, et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004; 279: 26274-26279. (Pubitemid 38798776)
39. Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99: 87-92. (Pubitemid 32522535)
40. Inui M, Fukui A, Ito Y, et al. Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol 2006; 298: 188-200. (Pubitemid 44414804)
41. Cox CM, D'Agostino SL, Miller MK, et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006; 296: 177-189. (Pubitemid 44061763)
42. Scott IC, Masri B, D'Amico LA, et al. The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell 2007; 12: 403-413. (Pubitemid 46313107)
43. Kalin RE, Kretz MP, Meyer AM, et al. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol 2007; 305: 599-614. (Pubitemid 46686624)
44. Takahashi T, Yamaguchi S, Chida K, et al. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001; 20: 2768-2778. (Pubitemid 32938560)
45. Hofer E, Schweighofer B. Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. Thromb Haemost 2007; 97: 355-363. (Pubitemid 46437796)
46. Masri B, Morin N, Cornu M, et al. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 2004; 18: 1909-1911. (Pubitemid 39602280)
47. Korff T, Augustin HG. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 1998; 143: 1341-1352. (Pubitemid 28559834)
48. Grant DS, Lelkes PI, Fukuda K, et al. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev Biol 1991; 27: 327-336.
49. Nicosia RF, Madri JA. The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol 1987; 128: 78-90. (Pubitemid 17094338)
50. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin- 1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169. (Pubitemid 27010100)
51. Takakura N, Watanabe T, Suenobu S, et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell 2000; 102: 199-209.
52. Okamoto R, Ueno M, Yamada Y, et al. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 2005; 105: 2757-2763. (Pubitemid 40446266)
53. Yamada Y, Takakura N. Physiological pathway of differentiation of hematopoietic stem cell population into mural cells. J Exp Med 2006; 203:1055-1065.
54. Okuda T, van Deursen J, Hiebert SW, et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-330. (Pubitemid 26042836)
55. Okada H, Watanabe T, Niki M, et al. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene 1998; 17: 2287-2293. (Pubitemid 28515381)
56. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409. (Pubitemid 34407037)
57. Huang PP, Yang XF, Li SZ, et al. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007; 98: 1335-1342. (Pubitemid 350239107)